HOME >> MEDICINE >> NEWS
A new math model finds that the cochlea's spiral shape enhances low frequencies

ctoral degree from the University of Washington, she was looking for work. At NIH, Chadwick was looking for someone with computer skills. He saw her website, was impressed by the computer model of blood vessel formation that she had created and offered her a job as a visiting fellow. That is where she got involved in the workings of the inner ear.

"I knew nothing about cochlea mechanics and I think that was to my advantage," Manoussaki says. "I looked at this organ that was shaped like a snail but that everyone was modeling as if it were a straight duct and I asked the obvious question."

Chadwick informed her that it was well established that the spiral shape did not affect the way that the cochlea functions. In order to motivate her, however, he proposed that they review the papers that came to this conclusion. So that is what they did, one paper after another. It took them more than two years but they finally concluded that none of the existing proofs were persuasive.

That realization led them to develop a mathematical model of the cochlea that included its helical structure. Their first model, which portrayed the cochlea as a helix of constant radius, did not show that the shape had any effects. At the end of her fellowship, Manoussaki returned home to Greece. In 2004, as she was preparing to return to the United States, she reconnected with her collaborators and began working on the problem once again.

This time they developed a more sophisticated model. When sound waves enter the ear, they strike the ear drum and cause it to vibrate. Tiny bones in the ear transmit these vibrations to the fluid in the cochlea, where they travel along the narrowing tube that winds into a spiral. The tube is divided into two chambers by an elastic membrane that runs down its length. The mechanical properties of this "basilar" membrane vary from very stiff at the outer end and becomes increasingly flexible as the chambers narrow. These changing prope
'"/>

Contact: David F. Salisbury
david.salisbury@vanderbilt.edu
615-343-6803
Vanderbilt University
8-May-2006


Page: 1 2 3

Related medicine news :

1. Test project of patient-centered medical home model endorsed by American College of Physicians
2. Chromatin remodeling complex connected to DNA damage control
3. Mouse model points to possible new strategy for treating rare muscle disease, kidney disorders
4. Green tea extract protects against brain damage in new mouse model of HIV-related dementia
5. Assessment model based on medical history gauges lung cancer risk
6. ISHLT membership explores expansion of computer modeling system for organ allocation
7. Johns Hopkins develops pancreas cancer risk model
8. Latest IPCC report highlights need for integrated climate/human behavior models
9. Transdermal vaccine effective in treating Alzheimers disease in mouse model
10. Structure essential for brain remodeling identified
11. Math model predicts cancer behavior

Post Your Comments:
(Date:5/21/2013)... Today, Zane Benefits, Inc. published a ... accounts. Zane Benefits, which provides comprehensive and flexible alternatives ... in defined contribution and http://HRA ... to Zane Benefits’ website, the Affordable Care Act (known ... in 2010 and impacts many areas of health care ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Two executives ... Guidance (SBG) will identify which strategies can be most ... high-quality care to the members who are taking them, ... Services, Inc., “How to Manage Specialty Drugs to ... pharmaceuticals are now the main driver for rising prescription ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 While North ... synonymous with comprehensive travel guides. Brunswick Plantation & Golf ... packages that include access to 27 holes of "Top10" ... courses in North Carolina, knowing the Top 10 ... Lodges takes away the overwhelming task of selecting the ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Octo ... technology and management consulting solutions to the Federal ... Business Development. In the newly created role, ... all aspects of the firm’s business development function ... proposal management functions, and leading strategies to achieve ...
(Date:5/21/2013)... HealthDay Reporter , , TUESDAY, May 21 (HealthDay News) ... therapy for patients having severe bouts of chronic obstructive ... days of glucocorticoid treatment with prednisone to treat COPD ... but with fewer chances for adverse side effects, they ... period of treatment was not less effective than 14 ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts 2Health News:Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts 3Health News:Consulting Firm Execs to Discuss Strategies for Effective Management of Specialty Drugs in AIS’s May 30 Webinar 2Health News:Brunswick Plantation & Golf Resort Named in Top 10 Golf Resorts in North Carolina 2Health News:Octo Consulting Group Appoints Tracy Denny as Vice President of Business Development 2Health News:COPD Patients May Do Fine With Shorter Course of Steroids 2Health News:COPD Patients May Do Fine With Shorter Course of Steroids 3
(Date:5/21/2013)... and TARRYTOWN, N.Y. , May 21, ... and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that ... online the positive Phase 2a study results of dupilumab ... an investigational monoclonal antibody targeting the alpha subunit of ... of both IL-4 and IL-13, drivers of Th2 (Type ...
(Date:5/21/2013)... Calif. , May 21, 2013 Abaxis, ... blood analysis systems, announced today that Martin ... at the Stifel Annual Dental & Veterinary Conference on ... conference will be held at Le Parker Meridien Hotel ... About Abaxis Abaxis develops, manufactures, markets ...
(Date:5/21/2013)... 2013 Reportlinker.com announces that a ... its catalogue:   ... Medical Devices in the US Market ... Changing Regulatory and Reimbursement Scenario for ...   Summary ...
Breaking Medicine Technology:Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 2Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 3Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 4Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 5Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 6Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 7Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference 2Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 2Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 3Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 4
Cached News: